JERSEY, Channel Islands, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage
diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Franz Walt, will present at the 2018
Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 3rd, 2018 at 4:00 p.m. EDT at The InterContinental
New York Barclay Hotel, in New York, NY. In addition, the Company will also host meetings on Tuesday, October 2nd,
2018. The Company's Chief Financial Officer, Chris Lindop, will also be participating in the conference.
A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at
www.quotientbd.com. A webcast replay will be archived on the website for approximately 90
days.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease
screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by
existing commercially available transfusion diagnostic instrument platforms. The company's operations are based in Edinburgh,
Scotland; Eysins, Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
CONTACT: Chris Lindop, Chief Financial Officer — chris.lindop@Quotientbd.com; +41 (0)799 61 69 38
